PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	337.34	308.05	224.5	136.19	75.01	34.47
Revenue Growth	22.69%	37.22%	64.84%	81.55%	117.60%	346.72%
Gross Profit Gross Profit Growth	213.75	196.23	137.1	71.05	37.09	15.87
Operating Income Operating Income Growth	-117.13	-103.86	-96.61	-109.17	-80.72	-54.16
Net Income Net Income Growth	-109.76	-95.57	-91.41	-105.9	-87.15	-59.85
Earnings Per Share EPS Growth	-1.95	-1.72	-1.75	-2.24	-1.96	-3.63
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
System Sales and Rentals System Sales and Rentals Growth	118.4	106.13	90.3	58.92	39.73	21.87
Hand-pieces and Other Consumables Hand-pieces and Other Consumables Growth	194.29	181.45	121.46	69.52	31.82	11.53
Service Service Growth	24.66	20.48	12.74	7.75	3.47	1.08
Revenue (Total) Revenue (Total) Growth	337.34	308.05	224.5	136.19	75.01	34.47

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	227.91	286.5	333.73	257.22	221.86	304.32
Total Debt Total Debt Growth	77.5	78.48	82.25	81.09	79.1	55.6
Net Cash (Debt) Net Cash Growth	150.41	208.02	251.48	176.13	142.76	248.72
Net Cash Growth	-32.66%	-17.28%	42.78%	23.37%	-42.60%	470.65%
Net Cash Per Share Net Cash Per Share Growth	2.67	3.75	4.82	3.73	3.22	15.09

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-74.34	-48.99	-99.21	-108	-80.38	-57.33
Capital Expenditures CapEx Growth	-10.59	-9.36	-4.41	-25.21	-2.65	-0.59
Free Cash Flow Free Cash Flow Growth	-84.93	-58.34	-103.62	-133.21	-83.04	-57.93
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	63.36%	63.70%	61.07%	52.17%	49.44%	46.02%
Operating Margin	-34.72%	-33.72%	-43.04%	-80.16%	-107.61%	-157.12%
Pretax Margin	-32.49%	-30.96%	-40.55%	-77.70%	-116.18%	-173.62%
Profit Margin	-32.53%	-31.02%	-40.72%	-77.76%	-116.18%	-173.62%
FCF Margin	-25.17%	-18.94%	-46.16%	-97.81%	-110.69%	-168.03%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	3.36	5.71	19.41	15.54	24.76	31.56

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error